roche holding ag-genusschein
(ROG:SIX Swiss Ex)
Transactions by ROCHE HOLDING AG-GENUSSCHEIN (ROG) in the last 6 months
Roche Holding AG (SWX:ROG) signed a definitive agreement to acquire InterMune, Inc. (NasdaqGS:ITMN) for $8 billion in cash on August 22, 2014. Under the terms of the agreement, Roche will commence a tender offer no later than August 29, 2014, to acquire all outstanding shares of InterMune common stock, and InterMune will file a recommendation statement containing the unanimous recommendation of the InterMune board that InterMune’s shareholders tender their shares to ...
Moore Capital Management, LP
Moore Global Investments, Ltd.
OrbiMed Advisors, L.L.C.
Visium Asset Management, LLC
Evercore Partners Inc.
The Goldman Sachs Group, Inc.
Stratos Genomics Inc. announced that it will receive $16,306,996 in funding on April 30, 2014. The company will issue equity securities in the transaction. The company will issue securities pursuant to exemption provided under Regulation D.
On May 13, 2014, the company announced that it has received $9,999,999 in the first tranche of its series B round if funding from a single investor. After the transaction, the company would have raised more than $26,000,000 in ...
|General Electric Co||$25.58 USD||+0.39|
|Gilead Sciences Inc||$107.19 USD||+1.10|
|Johnson & Johnson||$102.61 USD||+1.39|
|Merck & Co Inc||$56.74 USD||+1.23|
|Novartis AG||SFr.85.40 CHF||+0.75|
|View Industry Companies|